Table 2.

Medical history of patients included in the current study. Data are presented as median (Q1, Q3) or as n (%).

Characteristics	Values
Patients, n	223
Disease duration in years	5.00 (2.00; 10.0)
IGF1 value at diagnosis	731 (491; 923)
GH random value at diagnosis	11.1 (5.60; 25.7)
GH nadir post OGTT at diagnosis	8.8 (4.03; 17.3)
Adenoma size at diagnosis
Microadenoma	80 (35.8%)
Macroadenoma	143 (64.2%)
Neurosurgery
Transsphenoidal	167 (74.9%)
Transcranial	9 (4.04%)
None	47 (21.1%)
Hormonal deficit
1	39 (17.6%)
2	16 (7.2%)
3	5 (2.2%)
Replacement therapy*
No	177 (79.4%)
Yes	46 (20.6%)

*For hormonal deficiency at diagnosis.

GH, growth hormone; IGF1, insulin-like growth factor 1; OGTT, oral glucose tolerance test.